Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: New filing on ITC website

Notice of Clarification Regarding Final Initial Determination

....On page 119 of the ID, the ALJ "finds that the evidence is not sufficient to establish that the chips listed above meet this element of the asserted claims." The list of chips is located on page 88 of the Inition Determination

Share
New Message
Please login to post a reply